Daniel L. Hertz
Impact in
- Pharmacology top 0.2%
- Pharmacogenetics and Drug Metabolism
- Oncology top 2%
- Cancer Treatment and Pharmacology
- Colorectal Cancer Treatments and Studies
- Drug Transport and Resistance Mechanisms
Papers in
- Oncology 73
- Cancer Treatment and Pharmacology 53
- Colorectal Cancer Treatments and Studies 17
- HER2/EGFR in Cancer Research 6
- Pharmacology 36
- Pharmacogenetics and Drug Metabolism 35
- Co-authors
- Howard L. McLeod (13 shared papers)Elizabeth Smith (9 shared papers)James Michael Rae (29 shared papers)Maryam Lustberg (7 shared papers)Charles L. Loprinzi (4 shared papers)N. Lynn Henry (34 shared papers)Bryan Paul Schneider (3 shared papers)Thomas J. Smith (1 shared paper)
- Journals
- Pharmacogenomics (16 papers)Breast Cancer Research and Treatment (11 papers)Supportive Care in Cancer (10 papers)Clinical Pharmacology & Therapeutics (9 papers)Clinical Cancer Research (7 papers)
- Partner nations
- United StatesItalyCanada
In The Last Decade
Daniel L. Hertz
126 papers receiving 3.3k citations
Daniel L. Hertz's Hit Papers
Peers
Comparison fields: 5 of 130
- Pharmacology 812
- Oncology 1.7k
- Dermatology 231
- Hematology 255
- Transplantation 36
Countries citing papers authored by Daniel L. Hertz
This map shows the geographic impact of Daniel L. Hertz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel L. Hertz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel L. Hertz more than expected).
Fields of papers citing papers by Daniel L. Hertz
This network shows the impact of papers produced by Daniel L. Hertz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel L. Hertz. The network helps show where Daniel L. Hertz may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel L. Hertz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 140 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update Hit paper breakdown → | 2020 | 748 |
| 2 | Standardizing CYP 2D6 Genotype to Phenotype Translation: Consensus Recommendations from the Clinical Pharmacogenetics Implementation Consortium and Dutch Pharmacogenetics Working Group Hit paper breakdown → | 2019 | 417 |
| 3 | Vincristine-induced peripheral neuropathy in pediatric cancer patients. | 2016 | 137 |
| 4 | 2013 | 101 | |
| 5 | 2012 | 79 | |
| 6 | 2017 | 70 | |
| 7 | 2016 | 65 | |
| 8 | 2012 | 62 | |
| 9 | 2019 | 60 | |
| 10 | 2018 | 53 | |
| 11 | 2016 | 50 | |
| 12 | 2014 | 49 | |
| 13 | 2013 | 47 | |
| 14 | 2015 | 43 | |
| 15 | 2014 | 42 | |
| 16 | 2016 | 42 | |
| 17 | 2021 | 42 | |
| 18 | 2020 | 38 | |
| 19 | 2018 | 37 | |
| 20 | 2016 | 35 |
About Daniel L. Hertz
Daniel L. Hertz is a scholar working on Oncology, Pharmacology, Genetics, Hematology and Cancer Research, having authored 140 papers that have together received 3.4k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (53 papers), Pharmacogenetics and Drug Metabolism (35 papers), Estrogen and related hormone effects (20 papers), Colorectal Cancer Treatments and Studies (17 papers), Multiple Myeloma Research and Treatments (10 papers), Cancer Genomics and Diagnostics (7 papers), Chemotherapy-related skin toxicity (7 papers) and HER2/EGFR in Cancer Research (6 papers). The work is most often cited by research in Pharmacology (812 citations), Oncology (1.7k citations), Dermatology (231 citations), Hematology (255 citations) and Transplantation (36 citations). Daniel L. Hertz has collaborated with scholars based in United States, Italy and Canada. Frequent co-authors include Howard L. McLeod, Elizabeth Smith, James Michael Rae, Maryam Lustberg, Charles L. Loprinzi, N. Lynn Henry, Bryan Paul Schneider, Thomas J. Smith, Guido Cavaletti and Jonathan Scott Bleeker. Their work appears in journals such as Pharmacogenomics, Breast Cancer Research and Treatment, Supportive Care in Cancer, Clinical Pharmacology & Therapeutics and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.